Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
More Videos
The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare
America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.
Experian's AI Strategy Is Reshaping Financial Services
From Money 20/20, Experian UK & Ireland CEO Malin Holmberg discusses the trends, opportunities and innovations shaping fintech's future.
How The Brooklyn Army Terminal Became NYC's $100 Million Climate Hub
NYC just invested $100 million to turn a historic military base into a climate tech proving ground. We went inside the Brooklyn Army Terminal to find out why.
Why AI Companies May Soon Be Sharing Their Most Powerful Models With the Government
Politico's Cheyenne Haslett breaks down Trump's new AI executive order, the AI race with China, industry reaction, and what's next for regulation.
Inside the Aerospace IPO Positioning for the Next Decade of Defense Growth
Applied Aerospace & Defense CEO Trip Ferguson discusses the company's IPO, defense spending, space innovation, and the future of U.S. aerospace manufacturing.
How Crunch Fitness Is Redefining Your Exercise Routine
Jim Rowley, CEO of Crunch Fitness, discusses affordable fitness, industry growth, and why value-focused gyms continue to attract members.
